Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 62.53% is in line with its 5-year average of 59.61%, around the middle of its 5-year range (43.72%–81.50%).
2.19% below its 12-month average of 63.93%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 62.00%.
GROSS MARGIN
62.53%
GROSS MARGIN AVG TTM
63.93%
GROSS MARGIN AVG 3Y
63.49%
GROSS MARGIN AVG 5Y
59.61%
GROSS MARGIN AVG 10Y
61.50%
GROSS MARGIN AVG 15Y
43.91%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.19%
CURRENT VS 3Y AVG
-1.51%
CURRENT VS 5Y AVG
+4.90%
CURRENT VS 10Y AVG
+1.67%
CURRENT VS 15Y AVG
+42.39%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+51.11%
vs the sector median at left
Fortress Biotech, Inc.
Market Cap
$68.60M
Gross Margin
62.53%
TTM Avg
63.93%
3Y Avg
63.49%
5Y Avg
59.61%
Market Cap
$68.40M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$69.48M
Gross Margin
100.00%
TTM Avg
-0.84%
3Y Avg
37.19%
5Y Avg
-61.56%
Market Cap
$67.66M
Gross Margin
49.30%
TTM Avg
49.08%
3Y Avg
46.18%
5Y Avg
47.39%
Market Cap
$71.89M
Gross Margin
60.78%
TTM Avg
57.02%
3Y Avg
54.79%
5Y Avg
56.72%
Market Cap
$72.30M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
50.00%
5Y Avg
66.67%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | $68.60M | 62.53% | 63.93% | 63.49% | 59.61% |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spero Therapeutics, Inc. (SPRO)vs › | $69.48M | 100.00% | -0.84% | 37.19% | -61.56% |
| Champions Oncology, Inc. (CSBR)vs › | $67.66M | 49.30% | 49.08% | 46.18% | 47.39% |
| Cingulate Inc. (CING)vs › | $67.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| iBio, Inc. (IBIO)vs › | $66.56M | 100.00% | 100.00% | 75.00% | 39.52% |
| XBiotech Inc. (XBIT)vs › | $66.16M | 0.00% | 0.00% | 20.94% | 28.94% |
| MindWalk Holdings Corp. (HYFT)vs › | $71.89M | 60.78% | 57.02% | 54.79% | 56.72% |
| Gain Therapeutics, Inc. (GANX)vs › | $72.30M | 0.00% | 0.00% | 50.00% | 66.67% |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.16M | 85.89% | 77.06% | 82.88% | 71.27% |
Gross Margin
62.5%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 62.00% |
| 2026-03-31 | 54.21% |
| 2025-12-31 | 66.17% |
| 2025-09-30 | 67.36% |
| 2025-06-30 | 69.91% |
| 2025-03-31 | 63.54% |
| 2024-12-31 | 61.61% |
| 2024-09-30 | 63.87% |
| 2024-06-30 | 56.09% |
| 2024-03-31 | 53.94% |
| 2023-12-31 | 69.84% |
| 2023-09-30 | 81.50% |
| 2023-06-30 | 55.33% |
| 2023-03-31 | 48.11% |
| 2022-12-31 | 47.93% |
| 2022-09-30 | 56.31% |
| 2022-06-30 | 59.58% |
| 2022-03-31 | 65.71% |
| 2021-12-31 | 43.72% |
| 2021-09-30 | 47.04% |
| 2021-06-30 | 58.06% |
| 2021-03-31 | 66.27% |
| 2020-12-31 | 64.47% |
| 2020-09-30 | 64.34% |
| 2020-06-30 | 66.97% |
| 2020-03-31 | 70.51% |
| 2019-12-31 | 68.01% |
| 2019-09-30 | 72.35% |
| 2019-06-30 | 74.21% |
| 2019-03-31 | 70.91% |
| 2018-12-31 | 101.01% |
| 2018-09-30 | 20.81% |
| 2018-06-30 | 19.18% |
| 2018-03-31 | 17.41% |
| 2017-12-31 | 14.98% |
| 2017-09-30 | 12.68% |
| 2017-06-30 | 14.67% |
| 2017-03-31 | 13.90% |
| 2016-12-31 | 12.93% |
| 2016-09-30 | 95.79% |
| 2016-06-30 | 85.47% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | 100.00% |
| 2015-09-30 | 100.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 100.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
